Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence

Approximately 10–50% of patients treated for early-stage (I–III), resectable non-small cell lung cancer (eNSCLC) will develop locoregional recurrence. There is a lack of prospective trials evaluating optimal post-surgery follow-up for this patient population, and treatment guidelines recommend salva...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowes, Kathleen, Jovanoski, Nick, Brown, Audrey E., Di Maio, Danilo, Belleli, Rossella, Chadda, Shkun, Abogunrin, Seye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617826/
https://www.ncbi.nlm.nih.gov/pubmed/36308605
http://dx.doi.org/10.1007/s12032-022-01790-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617826/
https://www.ncbi.nlm.nih.gov/pubmed/36308605
http://dx.doi.org/10.1007/s12032-022-01790-0

Ejemplares similares